Gotham Asset Management’s ImmunityBio IBRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$93.1K Buy
+12,137
New +$83.1K ﹤0.01% 1725
2025
Q3
Sell
-16,224
Closed -$42.8K 1749
2025
Q2
$42.8K Sell
16,224
-28,781
-64% -$77.4K ﹤0.01% 1649
2025
Q1
$135K Buy
+45,005
New +$136K ﹤0.01% 1494
2024
Q3
Sell
-14,594
Closed -$92.2K 1471
2024
Q2
$92.2K Sell
14,594
-17,932
-55% -$118K ﹤0.01% 1384
2024
Q1
$175K Buy
32,526
+21,738
+202% +$98.4K ﹤0.01% 1299
2023
Q4
$54.2K Buy
+10,788
New +$33.9K ﹤0.01% 1308
2020
Q3
Sell
-27,855
Closed -$342K 1083
2020
Q2
$342K Buy
+27,855
New +$157K 0.01% 834
2017
Q3
Sell
-13,766
Closed -$104K 969
2017
Q2
$104K Buy
+13,766
New +$59.5K ﹤0.01% 929

Other funds holding IBRX